BioSpace News Archive

Shriners Hospitals for Children Researcher Reveals Important New Biology Leading to Improved Healing for Bone Fractures

Most people have broken a bone or know someone who has.

July 26, 2018
·
4 min read
Policy

Sandoz Amends ANDA to Not Seek Approval for Generic Version of OMIDRIA Until Patents for Omeros’ Drug Expire

With Voluntary Dismissal of Infringement Suit Against Sandoz, Omeros Wraps Up All Pending ANDA Litigation

July 26, 2018
·
5 min read
Business

Celgene Reports Second Quarter 2018 Operating and Financial Results

Strong total net product sales of $3.8 billion, increased 17% Y/Y

July 26, 2018
·
29 min read
Lone Star Bio

Nearly 40% of Consumers Interested in Digital Communication with Medical Professional

Speakers at Connected Health Summit to discuss expanding reach and functionality of virtual visits

July 26, 2018
·
3 min read
Biotech Beach

CureCervicalCancer Nearing Major Milestone of 100,000 Women Screened for Cervical Cancer

CureCervicalCancer (CCC) today announced they are just weeks away from reaching a major milestone of 100,000 women screened.

July 26, 2018
·
2 min read
Genetown

Magnolia Health to Sponsor Health Fair at Mayor’s Gospel Competition on Sept. 15

Magnolia Health announced that it will be hosting a city-wide health fair on Sept. 15 in conjunction with Mayor Lumumba’s Task Force for a Healthier Jackson’s Voices for Health Gospel Choir Competition.

July 26, 2018
·
2 min read
Business

NXT-ID Appoints Robert A. Curtis to Board of Directors

Bioscience veteran brings 35 years of health care industry experience to the Board

July 26, 2018
·
5 min read
Future Farm’s NexTech AR Solutions Signs Deal to Bring Hologrpahic Display Technology to Cannabis Market

Future Farm Technologies Inc. is pleased to announce that its partial subsidiary, NexTech AR Solutions, and ARHT Media Inc. have signed a worldwide exclusive license agreement to bring ARHT’s patented holographic display technology to the cannabis industry.

July 26, 2018
·
4 min read
This is How Marijuana Goes Global

There’s a huge investment opportunity unfolding right now, and it’s going largely unnoticed.

July 26, 2018
·
16 min read
Drug Development

Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme’s ENHANZE® Technology

Subcutaneous administration using Halozyme’s proprietary ENHANZE® drug-delivery technology in combination with chemotherapy.

July 26, 2018
·
4 min read